 |
|
Health Care Priority and Sickle Cell Anemia
Robert B. Scott, MD
JAMA. 1970;214(4):731-734.
Abstract
Health care priority for sickle cell anemia (SCA) should be based on its prevalence, severity, and on a standard of support set for similar conditions. Sickle cell anemia occurs in about one in 500 Negro births and median survival is still only 20 years of age. In 1967 there were an estimated 1,155 new cases of SCA, 1,206 of cystic fibrosis, 813 of muscular dystrophy, and 350 of phenylketonuria. Yet volunteer organizations raised $1.9 million for cystic fibrosis, $7.9 million for muscular dystrophy, but less than $100,000 for SCA. National Institutes of Health grants for many less common hereditary illnesses exceed those for SCA. Prevalence data in cities with sizeable black populations show that SCA is a major public health consideration. More appropriate priority for SCA depends on improved public and professional understanding of its importance.
Author Affiliations
From the Department of Medicine, Medical College of Virginia Health Sciences Center, Virginia Commonwealth University, Richmond.
Footnotes
Reprint requests to 1200 E Broad St, Richmond, Va 23219 (Dr. Scott).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Sickle Cell Disease: A Question of Equity and Quality
Smith et al.
Pediatrics 2006;117:1763-1770.
ABSTRACT
| FULL TEXT
Survival of children with sickle cell disease
Quinn et al.
Blood 2004;103:4023-4027.
ABSTRACT
| FULL TEXT
MOTHERHOOD AND THE OBFUSCATION OF MEDICAL KNOWLEDGE:: The Case of Sickle Cell Disease
HILL
Gender Society 1994;8:29-47.
ABSTRACT
Laboratory Diagnosis of Hemoglobinopathies
Schmidt
JAMA 1973;224:1276-1280.
ABSTRACT
A Comprehensive Screening Program for Hemoglobinopathies
Barnes et al.
JAMA 1972;219:701-705.
ABSTRACT
|
